NMN is a technical category with high consumer interest and a high risk of vague claims. A buyer needs a specification that can answer a laboratory question, a label question and a destination-market question without relying on the word longevity.
Confirm identity and assay
Request the raw-material identity method, finished-product assay, purity specification, capsule fill weight and batch certificate process. Ask whether the assay measures NMN itself or a broader NAD+ related signal. Stability data should show how the material behaves through packaging and shelf life.
Review the complete formula
Record NMN, TMG, quercetin and every excipient separately. Check serving size, capsule count, storage, allergen language and any country-specific restrictions. Supporting ingredients should not be used to imply that the combination has been clinically tested as a whole.
Separate research from product claims
A small 12-week human study found higher plasma NMN and NAD+ after 250 mg per day, while a 24-week study in older men did not improve grip strength or walking speed. This balanced evidence supports careful education, not promises of longevity, muscle performance or disease prevention. FDA guidance should be part of the claims review because context can create an implied disease claim.
ITAWEL reference product
ITAWEL NMN Capsules use a 120-capsule format and list NMN with TMG and quercetin in the product materials. Use SKU FB36621 when requesting the current specification, testing documents, sample, packaging files and destination-market quotation. Contact the ITAWEL distributor team to discuss the order.
Sources
- Oral NMN and plasma NMN and NAD+ study
- NMN and physical performance placebo-controlled study
- FDA: New dietary ingredients background for industry
- FDA: Dietary supplement CGMP guide
Educational content only. Product specifications, claims, MOQ, lead time and destination-market requirements must be confirmed for the actual order with ITAWEL.